Journal
JOURNAL OF NEUROSCIENCE RESEARCH
Volume 84, Issue 8, Pages 1716-1726Publisher
WILEY-LISS
DOI: 10.1002/jnr.21086
Keywords
dysmyelination; shiverer mutant mouse; MRI; visually evoked potential latency; T2-weighted magnetic resonance imaging
Categories
Funding
- NCRR NIH HHS [R01-RR13625, P41 RR12642] Funding Source: Medline
- NEI NIH HHS [R01-EY011933] Funding Source: Medline
- NIDA NIH HHS [P20-DA08944] Funding Source: Medline
- NIMH NIH HHS [R01-MH61223] Funding Source: Medline
Ask authors/readers for more resources
Visually evoked potentials (VEPs) and micromagnetic resonance imaging (mu MRI) are widely used as noninvasive techniques for diagnosis of central nervous system (CNS) diseases, especially myelin diseases, such as multiple sclerosis. Here we use these techniques in tan- dem to validate the in vivo data in mouse models. We used the shiverer mutant mouse, which has little or no CNS myelin, as a test model. These data show that shiverer (MBPshi/MBPshi) has a VEP latency that is 30% longer than that of its wild-type sibling. Surprisingly, the heterozygous (MBPshi/+) mouse, with apparently normal myelin, nevertheless has a 7% increase in its VEP latency vs. wild type. The mu MRIs of the same animals show that myelinated white matter is hypointense compared with gray matter as a result of the shorter T2 in myelinated regions of the CNS. T2-weighted images of wild-type and heterozygous shiverer mice show regions of hypointensity corresponding to the major myelinated tracts, including the optic nerve and the optic tract of the CNS, whereas shiverer mice have no regions of low intensity and therefore no detectable myelinated areas. In shiverer mice, mu MRI can discern hypomyelination throughout the brain, including the optic tract, and these changes correlate with longer VEP latencies. In addition, VEPs can also detect changes in the molecular make up of myelin that are not discernible with histology or mu MR. These data show the potential of using mu MRI in combination with VEPs to follow changes in both the quality and the quantity of myelin in vivo. These combined methods would be useful for longitudinal studies and therapy testing. (c) 2006 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available